Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03448367 · ClinicalTrials.gov registry record
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
A clinical trial, sponsored by Abbott Diabetes Care.
- Terminated
- Registry status
- 19
- Enrollment target
NCT03448367: Clinical Trial study, sponsored by Abbott Diabetes Care.
NCT03448367 is a clinical trial that was terminated before completion, run by Abbott Diabetes Care. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03448367 was terminated before completion, sponsored by Abbott Diabetes Care.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, non-randomized, single-arm, post-approval study of the FreeStyle Libre Flash Glucose Monitoring System intended to characterize the safety of the Libre Flash Glucose Monitoring System when used in pediatric patients with diabetes.
Primary Outcome
The study is designed to characterize the safety of the FreeStyle Libre Flash Glucose Monitoring System when used in the pediatric patient population.
Interventions
- DEVICE FreeStyle Libre Flash Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-02-27 |
| Est. Completion | 2020-10-13 |
Why NCT03448367 stopped before completion
NCT03448367 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre Flash Glucose Monitoring System is the first listed.
NCT03448367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03448367 about?
NCT03448367 is a clinical study titled "FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients". This is a prospective, multi-center, non-randomized, single-arm, post-approval study of the FreeStyle Libre Flash Glucose Monitoring System intended to characterize the safety of the Libre Flash Glucose Monitoring System when used in pediatric patients with diabetes.
What is the current status of trial NCT03448367?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2018-02-27. Estimated completion is 2020-10-13.
What interventions are being tested in trial NCT03448367?
The interventions under investigation include: FreeStyle Libre Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT03448367?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI